you are here: Home News Dr Lal Pathlabs

Dr Lal Pathlabs

Dr Lal PathLab Standalone September 2025 Net Sales at Rs 699.60 crore, up 19.82% Y-o-Y
Dr Lal PathLab Consolidated September 2025 Net Sales at Rs 730.60 crore, up 10.66% Y-o-Y
Dr Lal PathLab Consolidated June 2025 Net Sales at Rs 669.80 crore, up 11.28% Y-o-Y
Dr Lal PathLab Standalone June 2025 Net Sales at Rs 640.70 crore, up 19.87% Y-o-Y
Buy Dr Lal Pathlabs; target of Rs 3100: Emkay
Dr Lal PathLabs, Metropolis, others fall up to 2% as Amazon launches home diagnostics services
Hold Dr Lal Pathlabs: target of Rs 2,900: ICICI Securities
Buy Dr Lal Pathlabs; target of Rs 3100: Emkay Global Financial
Dr Lal PathLabs’ shares slip over 4% as margins likely to see pressure on expansion plans
Dr Lal PathLab Standalone March 2025 Net Sales at Rs 577.20 crore, up 20.5% Y-o-Y
Dr Lal PathLab Consolidated March 2025 Net Sales at Rs 602.60 crore, up 10.49% Y-o-Y
Dr Lal PathLab Consolidated December 2024 Net Sales at Rs 596.70 crore, up 10.73% Y-o-Y
Buy Dr Lal Pathlabs; target of Rs 3250: Emkay Global Financial
Dr Lal PathLab Standalone December 2024 Net Sales at Rs 528.10 crore, up 10.95% Y-o-Y
Dr Lal PathLab Standalone September 2024 Net Sales at Rs 583.90 crore, up 9.82% Y-o-Y
Trade Spotlight: How should you trade Bharti Hexacom, HCL Technologies, Granules India, Dr Lal PathLabs, BSE, and others on Thursday?
Hold Dr Lal Pathlabs; target of Rs 3100: ICICI Securities
Dr Lal PathLab Consolidated September 2024 Net Sales at Rs 660.20 crore, up 9.8% Y-o-Y
Dr Lal PathLab Standalone September 2024 Net Sales at Rs 583.90 crore, up 9.82% Y-o-Y
Stock Radar: HUL, Escorts Kubota, NLC India, Nuvoco Vistas, AU SFB, VIP Industries, Thyrocare, Dr Lal PathLabs in focus on Thursday
Trade Spotlight: How should you trade ICICI Bank, Phoenix Mills, Tube Investments of India, Unichem Labs and others on Wednesday?
Trade Spotlight: How should you trade Dr Lal PathLabs, JK Paper, Jubilant Ingrevia, Anant Raj and others on Monday?
Dr Lal PathLab Consolidated June 2024 Net Sales at Rs 601.90 crore, up 11.26% Y-o-Y
Hold Dr Lal Pathlabs; target of Rs 3,240: ICICI Securities
Dr Lal PathLab Standalone June 2024 Net Sales at Rs 534.50 crore, up 11.33% Y-o-Y

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Dr Lal Pathlabs

Dr Lal PathLab Standalone September 2025 Net Sales at Rs 699.60 crore, up 19.82% Y-o-Y

Dr Lal PathLab Consolidated September 2025 Net Sales at Rs 730.60 crore, up 10.66% Y-o-Y

Dr Lal PathLab Consolidated June 2025 Net Sales at Rs 669.80 crore, up 11.28% Y-o-Y

Dr Lal PathLab Standalone June 2025 Net Sales at Rs 640.70 crore, up 19.87% Y-o-Y

Buy Dr Lal Pathlabs; target of Rs 3100: Emkay

Dr Lal PathLabs, Metropolis, others fall up to 2% as Amazon launches home diagnostics services

Hold Dr Lal Pathlabs: target of Rs 2,900: ICICI Securities

Buy Dr Lal Pathlabs; target of Rs 3100: Emkay Global Financial

Dr Lal PathLabs’ shares slip over 4% as margins likely to see pressure on expansion plans

Dr Lal PathLab Standalone March 2025 Net Sales at Rs 577.20 crore, up 20.5% Y-o-Y

Dr Lal PathLab Consolidated March 2025 Net Sales at Rs 602.60 crore, up 10.49% Y-o-Y

Dr Lal PathLab Consolidated December 2024 Net Sales at Rs 596.70 crore, up 10.73% Y-o-Y

Buy Dr Lal Pathlabs; target of Rs 3250: Emkay Global Financial

Dr Lal PathLab Standalone December 2024 Net Sales at Rs 528.10 crore, up 10.95% Y-o-Y

Dr Lal PathLab Standalone September 2024 Net Sales at Rs 583.90 crore, up 9.82% Y-o-Y

Trade Spotlight: How should you trade Bharti Hexacom, HCL Technologies, Granules India, Dr Lal PathLabs, BSE, and others on Thursday?

Hold Dr Lal Pathlabs; target of Rs 3100: ICICI Securities

Dr Lal PathLab Consolidated September 2024 Net Sales at Rs 660.20 crore, up 9.8% Y-o-Y

Dr Lal PathLab Standalone September 2024 Net Sales at Rs 583.90 crore, up 9.82% Y-o-Y

Stock Radar: HUL, Escorts Kubota, NLC India, Nuvoco Vistas, AU SFB, VIP Industries, Thyrocare, Dr Lal PathLabs in focus on Thursday

Trade Spotlight: How should you trade ICICI Bank, Phoenix Mills, Tube Investments of India, Unichem Labs and others on Wednesday?

Trade Spotlight: How should you trade Dr Lal PathLabs, JK Paper, Jubilant Ingrevia, Anant Raj and others on Monday?

Dr Lal PathLab Consolidated June 2024 Net Sales at Rs 601.90 crore, up 11.26% Y-o-Y

Hold Dr Lal Pathlabs; target of Rs 3,240: ICICI Securities

Dr Lal PathLab Standalone June 2024 Net Sales at Rs 534.50 crore, up 11.33% Y-o-Y